5.17
-0.20 (-3.72%)
| 前收盘价格 | 5.37 |
| 收盘价格 | 5.36 |
| 成交量 | 1,440,708 |
| 平均成交量 (3个月) | 1,918,817 |
| 市值 | 919,547,072 |
| 价格/销量 (P/S) | 269.28 |
| 股市价格/股市净资产 (P/B) | 4.56 |
| 52周波幅 | |
| 利润日期 | 5 Nov 2025 |
| 营业利益率 (TTM) | -7,273.06% |
| 稀释每股收益 (EPS TTM) | -0.400 |
| 总债务/股东权益 (D/E MRQ) | 5.79% |
| 流动比率 (MRQ) | 8.33 |
| 营业现金流 (OCF TTM) | -44.17 M |
| 杠杆自由现金流 (LFCF TTM) | -25.01 M |
| 资产报酬率 (ROA TTM) | -26.41% |
| 股东权益报酬率 (ROE TTM) | -41.31% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 看涨 | 混合的 |
| Biotechnology (全球的) | 看涨 | 混合的 | |
| 股票 | Compass Therapeutics, Inc. | 看涨 | 看涨 |
AIStockmoo 评分
| 分析师共识 | 4.0 |
| 内部交易活动 | NA |
| 价格波动 | -4.5 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | 2.0 |
| 平均 | 0.38 |
|
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Value |
| 内部持股比例 | 14.16% |
| 机构持股比例 | 67.95% |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 30.00 (D. Boral Capital, 480.27%) | 购买 |
| 中 | 10.00 (93.42%) | |
| 低 | 10.00 (Canaccord Genuity, 93.42%) | 购买 |
| 10.00 (Citizens, 93.42%) | 购买 | |
| 平均值 | 16.67 (222.44%) | |
| 总计 | 3 购买 | |
| 平均价格@调整类型 | 5.16 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| D. Boral Capital | 06 Jan 2026 | 30.00 (480.27%) | 购买 | 4.91 |
| 05 Nov 2025 | 30.00 (480.27%) | 购买 | 3.82 | |
| Canaccord Genuity | 03 Dec 2025 | 10.00 (93.42%) | 购买 | 5.28 |
| Citizens | 03 Dec 2025 | 10.00 (93.42%) | 购买 | 5.28 |
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合